Exclusive

Publication

Byline

Location

Rajratan Global Wire has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

India, Oct. 23 -- As of September 2025, 65.13% is owned by Indian Promoters and 34.86% by Public. Institutional holds 8.86% (Insurance Companies 0.46%) and Non-Institutional holds 26.01% as Public sh... Read More


Share Samadhan L has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

India, Oct. 23 -- As of September 2025, 62.52% is owned by Indian Promoters and 37.48% by Public. Top five Promoters holding highest number of shares of Share Samadhan L company are Abhay Kumar Chand... Read More


Web Element Solution has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

India, Oct. 23 -- As of September 2025, 21.91% is owned by Indian Promoters and 78.09% by Public. Top five Promoters holding highest number of shares of Web Element Solution company are Nayan Jaswant... Read More


Whitehall Commercial has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

India, Oct. 23 -- As of September 2025, 72.39% is owned by Indian Promoters and 27.61% by Public. Top two Promoters holding highest number of shares of Whitehall Commercial company are Rightful Consu... Read More


Yaan Enterprises has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

India, Oct. 23 -- As of September 2025, 68.55% is owned by Indian Promoters and 31.45% by Public. Top four Promoters holding highest number of shares of Yaan Enterprises company are Ranjith Soman (13... Read More


Rupee gains 13 paise to 87.80 against US Dollar in early trade

India, Oct. 23 -- The Indian rupee strengthened by 13 paise to 87.80 against the US dollar in early trade on Thursday, supported by optimism surrounding a potential India–US trade deal. Accordi... Read More


Biocon gets Health Canada approval for Biosimilars Yesintek and Yesintek IV

India, Oct. 23 -- Biocon Ltd announced that its subsidiary, Biocon Biologics Ltd, has received approval from Health Canada for its biosimilar products Yesintek (ustekinumab injection) and Yesintek IV ... Read More


Nanomedic secures NHS Nod, Eyes India Launch and US FDA Filing

India, Oct. 23 -- Fischer Medical Ventures Ltd. (FMVL) announced that its portfolio company, Nanomedic Technologies Ltd., has achieved key global milestones, including registration of its flagship wou... Read More


Vikram Solar bags 148.9 MW order from Sunsure Energy to Boost India's Clean Energy Drive

India, Oct. 23 -- Vikram Solar, one of India's leading solar photovoltaic (PV) module manufacturers, has bagged a major order of 148.9 MW high-efficiency solar modules from Sunsure Energy, a prominent... Read More


Glenmark Pharma to Launch Ropivacaine Hydrochloride Injection in the U.S. by Nov 2025

India, Oct. 23 -- Glenmark Pharmaceuticals Inc., USA, has announced the upcoming launch of Ropivacaine Hydrochloride Injection USP in three strengths — 40 mg/20 mL (2 mg/mL), 150 mg/30 mL (5 mg/... Read More